MAXWELLIA

WE MAKE RX TO OTC INNOVATION HAPPEN

Maxwellia is an innovative pharma company and we convert prescription drugs into versions that can be bought in a pharmacy so that people can look after themselves.
 

We are building a pipeline of new consumer healthcare brands in ground breaking categories to tackle future Public Health priorities. We have three products in our pipeline and intend to start commercialisation in 2020.
 

We also offer our switching expertise and capability services to small and mid-sized pharmaceutical companies in UK/EU.
 

OUR SERVICES AND OFFERINGS

Rx to OTC Switching Capability - find out more

Maxwellia is a collaboration of the UK’s leading experts in the reclassification of medicines who are working on a number of our own  initiatives to help tackle growing public health issues that adversely affect the quality of life of many sufferers, our people centric approach is unique.

 

We want to improve the way reclassified medicines are designed and commercialised and have developed our own process Dynamic Switch™ to make Rx to OTC switching simpler, faster, cheaper and more likely to succeed.

INVESTORS

CAPABILITY & CONSULTANCY

SWITCH IN A BOX

SWITCH IN A BOX

Does your company need help getting started with an Rx to OTC Switch? Message us today.

 
OUR SERVICES AND OFFERINGS
 STRATEGIES AND CLEVER SOLUTIONS

We Help You Stay Ahead

Maxwellia has worked on enough switches to know that no two are the same. We’re passionate about coming up with solutions that focus on simplicity, practicality, and impact. We adapt how our clients do business to the rapidly-changing marketplace. Contact us and learn how you can stay ahead.

SwitchScreen

Get Started

SwitchUp

Identify Critical Success Factors

SwitchAbility

Make It Happen

Make sure your switch is wired for success . Call us now to find out how!

 
WHAT WE BELIEVE

Switch Dynamics 

There are many compelling reasons to make medicines more widely available, not least so people can take greater responsibility for their own self care.

​Switch Dynamics is a practical guide for those in pharmaceutical companies considering switch projects for drugs, including Rx to OTC, POM to P and P to GSL.

The book considers past UK switches, with key learning and a framework for initiating, setting up and running switch projects within companies and commercialising them.​ There are 10 case studies, insight and practical experience to help key people plan and manage the process so that they can confidently implement a switch programme with the best chance of success.​​​​​​​​​ 

 Wire your switch for success.

 
CONTACT US!

Join our mailing list to receive the latest switch news as it happens

MEET OUR TEAM

ANNA MAXWELL

Founder & CEO

Self Care visionary, author, entrepreneur, pharmacist, medicines reclassification and marketing commercialisation specialist. Anna is passionate about widening access to medicines and is building Maxwellia to make it happen.

DR STEPHEN MANN

Medical & Scientific Lead

Steve is a medic and Self Care innovator he's our ideas guy. He has been closely involved on a wide range of switches across many therapeutic areas including gastrointestinal, infectious diseases, cardiovascular, urology, neuroscience and dermatology.

DR MERLE BEAL

Regulatory Lead

Merle has a PhD in pharmacy and is our regulatory guru. She provides top strategic regulatory advice for our switch operations and has a breadth of global experience in the reclassification of medicines for Self Care.
If there is a way then Merle will find it.

DR MERLE BEAL

Regulatory Lead

Merle has a PhD in pharmacy and is our regulatory guru. She provides top strategic regulatory advice for our switch operations and has a breadth of global experience in the reclassification of medicines for Self Care.
If there is a way then Merle will find it.

DR MERLE BEAL

Regulatory Lead

Merle has a PhD in pharmacy and is our regulatory guru. She provides top strategic regulatory advice for our switch operations and has a breadth of global experience in the reclassification of medicines for Self Care.
If there is a way then Merle will find it.

MEET OUR TEAM

ANNA MAXWELL

Founder & CEO

Self Care visionary, author, entrepreneur, pharmacist, medicines reclassification and marketing commercialisation specialist. Anna is passionate about widening access to medicines and is building Maxwellia to make it happen.

DR STEPHEN MANN

Medical & Scientific Lead

Steve is a medic and Self Care innovator he's our ideas guy. He has been closely involved on a wide range of switches across many therapeutic areas including gastrointestinal, infectious diseases, cardiovascular, urology, neuroscience and dermatology.

DR MERLE BEAL

Regulatory Lead

Merle has a PhD in pharmacy and is our regulatory guru. She provides top strategic regulatory advice for our switch operations and has a breadth of global experience in the reclassification of medicines for Self Care.
If there is a way then Merle will find it.

ALEXANDRA TREHANE

Head of Innovation

Alex is passionate about Self Care. She is responsible for picking the winners and bringing our ideas to life to deliver useful and better  brands that consumers want to buy.  Alex is known for pushing  

boundaries  and rolling up her sleeves to get the job done. 

PETER BALLARD

Director

Peter is an experienced pharma executive and chair of the British Generics Manufacturers Association. He has considerable M&A and in-licencing experience. He is our 'fixer', supporting our business development and finding solutions to complex problems.

 Alderley Park, Alderley Edge, SK10 4TG

©2020 by Maxwellia